Nuclear factor-κb is selectively and markedly activated in humans with unstable angina pectoris

Circulation

Volumn 98, Issue 17, 1998, Pages 1707-1713

  Ritchie, Michael E ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angina; Coronary disease; Inflammation; NF kappa B

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ANGINA PECTORIS; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROPHORETIC MOBILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; UNSTABLE ANGINA PECTORIS; VALVULAR HEART DISEASE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; METABOLISM; MIDDLE AGED; RUPTURE; SYNDROME;

ANGINA, UNSTABLE; CORONARY ARTERIOSCLEROSIS; HUMANS; MIDDLE AGED; NF-KAPPA B; RUPTURE, SPONTANEOUS; SYNDROME;

EID: 0032573018     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.17.1707     Document Type: Article

References (42)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-808.
2. Munro JM, Cotran RS. Biology of disease: the pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest. 1988;58:279-281.
3. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulation of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131-138.
4. Sato T, Takebayashi S, Kohehi K. Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina. Atherosclerosis. 1995;68:191-197.
5. Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti D, Bramucci E, Angoli L, Marsico F, Specchia G, Notario A. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation. 1993;88:358-363.
6. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A. 1987;84:2995-2998.
7. Stemme S, Holm J, Hansson GK. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb. 1992;12:206-211.
8. Neri Serneri GG, Abbate R, Gori AM, Attanasio M, Martini F, Giusti B, Dabizzi P, Poggesi L, Modesti PA, Trotta F, Rostagno C, Boddi M, Genisini GF. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation. 1992;86:790-797.
9. van der Wal AC, Becer AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
10. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331: 417-424.
11. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
12. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
13. Barnes PJ, Karin M. Mechanisms of disease: nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1041-1045.
14. Lenardo MJ, Baltimore D. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 1989;58:227-229.
15. Beg AA, Baldwin AS. The IkB proteins: multifunctional regulators of Rel/NF-kB transcription factors. Genes Dev. 1993;7:2064-2070.
16. Kopp E, Ghosh S. Inhibition of NFκB by sodium salicylate and aspirin. Science. 1994;265:956-959.
17. Cairns A, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA, Jablonsky G, Kostuk W, Melendex LJ, Myers MG, Sackett DL, Sealey BJ, Tanser PH. Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian Multicenter Trial. N Engl J Med. 1985;313: 1369-1375.
18. Lewes HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study. N Engl J Med. 1983;309:396-403.
19. Bataille R, Klein B. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum. 1992;35: 982-984.
20. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
21. Schreiber E, Matthias P, Muller M, Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts" prepared from a small number of cells. Nucleic Acids Res. 1989;17:6419.
22. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current Protocols in Molecular Biology. New York, NY: John Wiley and Sons Inc; 1994:12.2.2-12.1.26.
23. Bradford MM. A rapid and sensitive method for the condition of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1967;72:248-254.
24. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current Protocols in Molecular Biology. New York, NY: John Wiley and Sons Inc; 1994:3.10.2-3.10.3.
25. Ferber MJ, Maher J III. Quantitating oligonucleotide affinities for duplex DNA: footprinting vs. electrophoretic mobility shift assays. Anal Biochem. 1997;244:312-320.
26. Cooney M, Czernuszewiccz G, Postel EH, Flint JS, Hogan ME. Site specific oligonucleotide binding represses transcription of the human c-myc gene in vivo. Science. 1988;241:456-459.
27. Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Borrows MT, Kahl FR, Santamore WP. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:1157-1166.
28. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
29. Hou J, Baichwal V, Z Cao V. Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding ICAM-1. Proc Natl Acad Sci U S A. 1994;91:11641-11645.
30. Shu HB, Agranoff AB, Nabel EG, Leung K, Duckett CS, Neish AS, Collins T, Nabel G. Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NFκB subunits in endothelial and epithelial cells. Mol Cell Biol. 1994;13:6283-6289.
31. Zieher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res. 1995;76:980-986.
32. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715-1722.
33. Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA. Role of nuclear factor-kappa B in atherogenesis. Exp Physiol. 1997;82:297-304.
34. Hernandez-Presa M, Bustos C, Ortego M, Tunon J, Renedo G, Ruiz-Ortega M, Egido J. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation. 1997;95:1532-1541.
35. Neumann FJ, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, Sticherling C, Meinl C, May A, Schomig A. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation. 1997;95:2387-2394.
36. Bourcier T, Sukhova G, Libby P. The nuclear factor κ-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem. 1997;272:15817-15824.
37. Spieker M, Peng H-B, Liao JK. Regulation of NFκB inhibitor IκBα by nitric oxide donors. Circulation. 1997;96(suppl I):I-502. Abstract.
38. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 1995;9: 899-909.
39. Hishikawa K, Oemar BS, Yang Z, Luscher TF. Pulsatile stretch stimulates superoxide production and activates nuclear factor-kappa B in human coronary smooth muscle. Circ Res. 1997;81:796-803.
40. Brand K, Eisele T, Kreusel U, Page M, Page S, Haas M, Gerling A, Kaltschmidt C, Neumann FJ, Mackman N, Baeurele PA, Walli AK, Neumeier D. Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol. 1997;17:1901-1909.
41. Wrenshall LE, Cerra FB, Singh RK, Platt JL. Heparan sulfate initiates signals in murine macrophages leading to divergent biologic outcomes. J Immunol. 1995;154:871-880.
42. Blackwell TS, Christman JW. The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol. 1997;17:3-9.